Literature DB >> 120745

[Antibacterial activity of mezlocillin and azlocillin/A survey (author's transl)].

H Knothe.   

Abstract

A review of the antibacterial activity of 6-[(R)-2-[3-methylsulfonyl-2-oxo-imidazolidine-carboxamido]-2-phenyl-acetamido]-penicillanic acid sodium salt (mezlocillin, Baypen) and 6-[(R)-2-(2-oxo-imidazolidine-1-carboxamido)-2-phenyl-acetamido]-penicillanic acid sodium salt (azlocillin, Securopen) is given on the basis of extensive in vitro studies. The action of each of the preparations is compared with that of important antibiotics of other substance classes from the group of penicillins and cephalosporins.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 120745

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  7 in total

1.  [Systemic mezlocillin prophylaxis in elective colon surgery].

Authors:  M Wenzel; M Walden; M Heinrich; B Neuhaus
Journal:  Infection       Date:  1982       Impact factor: 3.553

2.  [Concentrations of mezlocillin in cerebrospinal fluid in vira meningitis (author's transl)].

Authors:  H G Hoffmann; D Förster; I Schoen
Journal:  Infection       Date:  1980       Impact factor: 3.553

3.  [N-formimidoyl-thienamycin: in vitro activity in bacteria with resistance to beta-lactam antibiotics or gentamicin].

Authors:  K Bartmann; R Tarbuc
Journal:  Infection       Date:  1982 Nov-Dec       Impact factor: 3.553

4.  [Microbiological studies with the new penicillin BRL 17421 (temocillin)].

Authors:  R Malottke; J Potel
Journal:  Infection       Date:  1983 Jan-Feb       Impact factor: 3.553

5.  [Mezlocillin in neonatal medicine].

Authors:  U Sitka; L Weingärtner; R Patsch
Journal:  Infection       Date:  1982       Impact factor: 3.553

6.  [Mezlocillin concentrations in human lung tissue].

Authors:  U Kroening; S Liebig; M Wundschock
Journal:  Infection       Date:  1982       Impact factor: 3.553

7.  Mezlocillin and carbenicillin: a clinical comparison of serious systemic infections in surgical patients.

Authors:  A Lewandowski; T Orlowski; H Weuta
Journal:  Infection       Date:  1982       Impact factor: 3.553

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.